nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—ACHE—prostate cancer	0.395	0.783	CbGaD
Pyridostigmine—CYP3A4—prostate cancer	0.109	0.217	CbGaD
Pyridostigmine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0599	0.207	CbGbCtD
Pyridostigmine—CYP3A4—Bicalutamide—prostate cancer	0.0315	0.109	CbGbCtD
Pyridostigmine—CYP3A4—Estramustine—prostate cancer	0.0292	0.101	CbGbCtD
Pyridostigmine—CYP3A4—Abiraterone—prostate cancer	0.0261	0.09	CbGbCtD
Pyridostigmine—CYP3A4—Flutamide—prostate cancer	0.0261	0.09	CbGbCtD
Pyridostigmine—CYP3A4—Cabazitaxel—prostate cancer	0.0193	0.0666	CbGbCtD
Pyridostigmine—CYP3A4—Estrone—prostate cancer	0.0188	0.0651	CbGbCtD
Pyridostigmine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0168	0.058	CbGbCtD
Pyridostigmine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0123	0.0426	CbGbCtD
Pyridostigmine—CYP3A4—Mitoxantrone—prostate cancer	0.0112	0.0387	CbGbCtD
Pyridostigmine—CYP3A4—Estradiol—prostate cancer	0.0108	0.0374	CbGbCtD
Pyridostigmine—CYP3A4—Prednisone—prostate cancer	0.00931	0.0321	CbGbCtD
Pyridostigmine—CYP3A4—Etoposide—prostate cancer	0.00707	0.0244	CbGbCtD
Pyridostigmine—CYP3A4—Docetaxel—prostate cancer	0.00647	0.0223	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—prostate cancer	0.00482	0.0166	CbGbCtD
Pyridostigmine—Neostigmine—ACHE—prostate cancer	0.00174	0.439	CrCbGaD
Pyridostigmine—Rivastigmine—ACHE—prostate cancer	0.00174	0.439	CrCbGaD
Pyridostigmine—Rivastigmine—CYP3A4—prostate cancer	0.000482	0.122	CrCbGaD
Pyridostigmine—Pulmonary oedema—Epirubicin—prostate cancer	0.000147	0.00107	CcSEcCtD
Pyridostigmine—Nausea—Bicalutamide—prostate cancer	0.000146	0.00107	CcSEcCtD
Pyridostigmine—Loss of consciousness—Estradiol—prostate cancer	0.000146	0.00107	CcSEcCtD
Pyridostigmine—Cardiac arrest—Prednisone—prostate cancer	0.000146	0.00106	CcSEcCtD
Pyridostigmine—Sweating increased—Capecitabine—prostate cancer	0.000145	0.00106	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—prostate cancer	0.000145	0.00106	CcSEcCtD
Pyridostigmine—Bronchitis—Capecitabine—prostate cancer	0.000143	0.00104	CcSEcCtD
Pyridostigmine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000142	0.00104	CcSEcCtD
Pyridostigmine—Myalgia—Estradiol—prostate cancer	0.000142	0.00103	CcSEcCtD
Pyridostigmine—Feeling abnormal—Goserelin—prostate cancer	0.000141	0.00103	CcSEcCtD
Pyridostigmine—Dry skin—Prednisone—prostate cancer	0.000141	0.00102	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Goserelin—prostate cancer	0.00014	0.00102	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000139	0.00101	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—prostate cancer	0.000139	0.00101	CcSEcCtD
Pyridostigmine—Confusional state—Estradiol—prostate cancer	0.000137	0.000997	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—prostate cancer	0.000136	0.000992	CcSEcCtD
Pyridostigmine—Urticaria—Goserelin—prostate cancer	0.000136	0.000991	CcSEcCtD
Pyridostigmine—Abdominal pain—Goserelin—prostate cancer	0.000135	0.000986	CcSEcCtD
Pyridostigmine—Urticaria—Conjugated Estrogens—prostate cancer	0.000135	0.000982	CcSEcCtD
Pyridostigmine—Convulsion—Mitoxantrone—prostate cancer	0.000134	0.000978	CcSEcCtD
Pyridostigmine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000134	0.000977	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—prostate cancer	0.000134	0.000977	CcSEcCtD
Pyridostigmine—Abdominal distension—Prednisone—prostate cancer	0.000133	0.000973	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—prostate cancer	0.000133	0.000968	CcSEcCtD
Pyridostigmine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000132	0.000964	CcSEcCtD
Pyridostigmine—Myalgia—Mitoxantrone—prostate cancer	0.000132	0.000961	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Estradiol—prostate cancer	0.000131	0.000956	CcSEcCtD
Pyridostigmine—Rash—Ethinyl Estradiol—prostate cancer	0.000131	0.000956	CcSEcCtD
Pyridostigmine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000131	0.000955	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—prostate cancer	0.000131	0.000953	CcSEcCtD
Pyridostigmine—Headache—Ethinyl Estradiol—prostate cancer	0.00013	0.00095	CcSEcCtD
Pyridostigmine—Epistaxis—Docetaxel—prostate cancer	0.000129	0.000942	CcSEcCtD
Pyridostigmine—Sweating increased—Prednisone—prostate cancer	0.000129	0.000941	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—prostate cancer	0.000128	0.000934	CcSEcCtD
Pyridostigmine—Confusional state—Mitoxantrone—prostate cancer	0.000127	0.000929	CcSEcCtD
Pyridostigmine—Hypersensitivity—Goserelin—prostate cancer	0.000126	0.000919	CcSEcCtD
Pyridostigmine—Epistaxis—Capecitabine—prostate cancer	0.000125	0.000912	CcSEcCtD
Pyridostigmine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000125	0.00091	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—prostate cancer	0.000124	0.000903	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000124	0.000901	CcSEcCtD
Pyridostigmine—Nausea—Ethinyl Estradiol—prostate cancer	0.000124	0.0009	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—prostate cancer	0.000123	0.000896	CcSEcCtD
Pyridostigmine—Asthenia—Goserelin—prostate cancer	0.000123	0.000895	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Docetaxel—prostate cancer	0.000122	0.000892	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—prostate cancer	0.000122	0.000892	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000122	0.000891	CcSEcCtD
Pyridostigmine—Paraesthesia—Estradiol—prostate cancer	0.000122	0.000888	CcSEcCtD
Pyridostigmine—Asthenia—Conjugated Estrogens—prostate cancer	0.000122	0.000887	CcSEcCtD
Pyridostigmine—Bradycardia—Capecitabine—prostate cancer	0.000121	0.000884	CcSEcCtD
Pyridostigmine—Somnolence—Estradiol—prostate cancer	0.000121	0.000879	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Capecitabine—prostate cancer	0.000118	0.000864	CcSEcCtD
Pyridostigmine—Hypotension—Mitoxantrone—prostate cancer	0.000118	0.000861	CcSEcCtD
Pyridostigmine—Diarrhoea—Goserelin—prostate cancer	0.000117	0.000854	CcSEcCtD
Pyridostigmine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000116	0.000846	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—prostate cancer	0.000116	0.000844	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000115	0.00084	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—prostate cancer	0.000114	0.000831	CcSEcCtD
Pyridostigmine—Paraesthesia—Mitoxantrone—prostate cancer	0.000114	0.000827	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—prostate cancer	0.000113	0.000826	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—prostate cancer	0.000113	0.000825	CcSEcCtD
Pyridostigmine—Somnolence—Mitoxantrone—prostate cancer	0.000112	0.000819	CcSEcCtD
Pyridostigmine—Feeling abnormal—Estradiol—prostate cancer	0.000112	0.000815	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—prostate cancer	0.000112	0.000814	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Estradiol—prostate cancer	0.000111	0.000809	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—prostate cancer	0.00011	0.000801	CcSEcCtD
Pyridostigmine—Vomiting—Goserelin—prostate cancer	0.000109	0.000793	CcSEcCtD
Pyridostigmine—Alopecia—Docetaxel—prostate cancer	0.000109	0.000792	CcSEcCtD
Pyridostigmine—Bradycardia—Prednisone—prostate cancer	0.000108	0.000787	CcSEcCtD
Pyridostigmine—Rash—Goserelin—prostate cancer	0.000108	0.000787	CcSEcCtD
Pyridostigmine—Dermatitis—Goserelin—prostate cancer	0.000108	0.000786	CcSEcCtD
Pyridostigmine—Vomiting—Conjugated Estrogens—prostate cancer	0.000108	0.000786	CcSEcCtD
Pyridostigmine—Urticaria—Estradiol—prostate cancer	0.000108	0.000786	CcSEcCtD
Pyridostigmine—Abdominal pain—Estradiol—prostate cancer	0.000107	0.000782	CcSEcCtD
Pyridostigmine—Headache—Goserelin—prostate cancer	0.000107	0.000782	CcSEcCtD
Pyridostigmine—Rash—Conjugated Estrogens—prostate cancer	0.000107	0.000779	CcSEcCtD
Pyridostigmine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000107	0.000778	CcSEcCtD
Pyridostigmine—Headache—Conjugated Estrogens—prostate cancer	0.000106	0.000774	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—prostate cancer	0.000106	0.000773	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—prostate cancer	0.000106	0.000769	CcSEcCtD
Pyridostigmine—Alopecia—Capecitabine—prostate cancer	0.000105	0.000767	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—prostate cancer	0.000104	0.000761	CcSEcCtD
Pyridostigmine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000104	0.000759	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—prostate cancer	0.000104	0.000756	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000103	0.000754	CcSEcCtD
Pyridostigmine—Muscle spasms—Docetaxel—prostate cancer	0.000103	0.00075	CcSEcCtD
Pyridostigmine—Flatulence—Capecitabine—prostate cancer	0.000102	0.000745	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—prostate cancer	0.000102	0.000741	CcSEcCtD
Pyridostigmine—Nausea—Goserelin—prostate cancer	0.000102	0.000741	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—prostate cancer	0.000102	0.000741	CcSEcCtD
Pyridostigmine—Nausea—Conjugated Estrogens—prostate cancer	0.000101	0.000734	CcSEcCtD
Pyridostigmine—Urticaria—Mitoxantrone—prostate cancer	0.0001	0.000732	CcSEcCtD
Pyridostigmine—Hypersensitivity—Estradiol—prostate cancer	9.99e-05	0.000729	CcSEcCtD
Pyridostigmine—Abdominal pain—Mitoxantrone—prostate cancer	9.99e-05	0.000728	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—prostate cancer	9.97e-05	0.000727	CcSEcCtD
Pyridostigmine—Muscle spasms—Capecitabine—prostate cancer	9.97e-05	0.000727	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—prostate cancer	9.82e-05	0.000716	CcSEcCtD
Pyridostigmine—Asthenia—Estradiol—prostate cancer	9.73e-05	0.00071	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—prostate cancer	9.65e-05	0.000704	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—prostate cancer	9.59e-05	0.000699	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—prostate cancer	9.57e-05	0.000698	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—prostate cancer	9.44e-05	0.000688	CcSEcCtD
Pyridostigmine—Loss of consciousness—Docetaxel—prostate cancer	9.41e-05	0.000686	CcSEcCtD
Pyridostigmine—Alopecia—Prednisone—prostate cancer	9.37e-05	0.000683	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—prostate cancer	9.35e-05	0.000681	CcSEcCtD
Pyridostigmine—Vertigo—Capecitabine—prostate cancer	9.31e-05	0.000679	CcSEcCtD
Pyridostigmine—Hypersensitivity—Mitoxantrone—prostate cancer	9.31e-05	0.000679	CcSEcCtD
Pyridostigmine—Diarrhoea—Estradiol—prostate cancer	9.28e-05	0.000677	CcSEcCtD
Pyridostigmine—Convulsion—Docetaxel—prostate cancer	9.28e-05	0.000676	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—prostate cancer	9.24e-05	0.000674	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—prostate cancer	9.22e-05	0.000672	CcSEcCtD
Pyridostigmine—Myalgia—Docetaxel—prostate cancer	9.11e-05	0.000665	CcSEcCtD
Pyridostigmine—Loss of consciousness—Capecitabine—prostate cancer	9.11e-05	0.000664	CcSEcCtD
Pyridostigmine—Asthenia—Mitoxantrone—prostate cancer	9.07e-05	0.000661	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—prostate cancer	8.86e-05	0.000646	CcSEcCtD
Pyridostigmine—Myalgia—Capecitabine—prostate cancer	8.82e-05	0.000643	CcSEcCtD
Pyridostigmine—Confusional state—Docetaxel—prostate cancer	8.81e-05	0.000642	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—prostate cancer	8.72e-05	0.000635	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—prostate cancer	8.66e-05	0.000632	CcSEcCtD
Pyridostigmine—Diarrhoea—Mitoxantrone—prostate cancer	8.65e-05	0.000631	CcSEcCtD
Pyridostigmine—Vomiting—Estradiol—prostate cancer	8.63e-05	0.000629	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—prostate cancer	8.6e-05	0.000627	CcSEcCtD
Pyridostigmine—Rash—Estradiol—prostate cancer	8.55e-05	0.000624	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—prostate cancer	8.55e-05	0.000623	CcSEcCtD
Pyridostigmine—Dermatitis—Estradiol—prostate cancer	8.55e-05	0.000623	CcSEcCtD
Pyridostigmine—Confusional state—Capecitabine—prostate cancer	8.53e-05	0.000622	CcSEcCtD
Pyridostigmine—Headache—Estradiol—prostate cancer	8.5e-05	0.00062	CcSEcCtD
Pyridostigmine—Agitation—Prednisone—prostate cancer	8.49e-05	0.000619	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—prostate cancer	8.45e-05	0.000616	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—prostate cancer	8.35e-05	0.000609	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—prostate cancer	8.31e-05	0.000606	CcSEcCtD
Pyridostigmine—Vertigo—Prednisone—prostate cancer	8.3e-05	0.000605	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—prostate cancer	8.25e-05	0.000602	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Capecitabine—prostate cancer	8.18e-05	0.000596	CcSEcCtD
Pyridostigmine—Hypotension—Docetaxel—prostate cancer	8.16e-05	0.000595	CcSEcCtD
Pyridostigmine—Loss of consciousness—Prednisone—prostate cancer	8.12e-05	0.000592	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—prostate cancer	8.06e-05	0.000588	CcSEcCtD
Pyridostigmine—Nausea—Estradiol—prostate cancer	8.06e-05	0.000587	CcSEcCtD
Pyridostigmine—Vomiting—Mitoxantrone—prostate cancer	8.04e-05	0.000586	CcSEcCtD
Pyridostigmine—Convulsion—Prednisone—prostate cancer	8e-05	0.000583	CcSEcCtD
Pyridostigmine—Rash—Mitoxantrone—prostate cancer	7.97e-05	0.000581	CcSEcCtD
Pyridostigmine—Dermatitis—Mitoxantrone—prostate cancer	7.96e-05	0.000581	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.96e-05	0.00058	CcSEcCtD
Pyridostigmine—Headache—Mitoxantrone—prostate cancer	7.92e-05	0.000577	CcSEcCtD
Pyridostigmine—Hypotension—Capecitabine—prostate cancer	7.91e-05	0.000576	CcSEcCtD
Pyridostigmine—Myalgia—Prednisone—prostate cancer	7.86e-05	0.000573	CcSEcCtD
Pyridostigmine—Paraesthesia—Docetaxel—prostate cancer	7.85e-05	0.000572	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—prostate cancer	7.81e-05	0.00057	CcSEcCtD
Pyridostigmine—Somnolence—Docetaxel—prostate cancer	7.77e-05	0.000566	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—prostate cancer	7.75e-05	0.000565	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.71e-05	0.000562	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—prostate cancer	7.64e-05	0.000557	CcSEcCtD
Pyridostigmine—Paraesthesia—Capecitabine—prostate cancer	7.6e-05	0.000554	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—prostate cancer	7.54e-05	0.00055	CcSEcCtD
Pyridostigmine—Nausea—Mitoxantrone—prostate cancer	7.51e-05	0.000547	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—prostate cancer	7.33e-05	0.000534	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Prednisone—prostate cancer	7.28e-05	0.000531	CcSEcCtD
Pyridostigmine—Feeling abnormal—Docetaxel—prostate cancer	7.2e-05	0.000525	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—prostate cancer	7.19e-05	0.000524	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Docetaxel—prostate cancer	7.15e-05	0.000521	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—prostate cancer	7.12e-05	0.000519	CcSEcCtD
Pyridostigmine—Feeling abnormal—Capecitabine—prostate cancer	6.97e-05	0.000508	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—prostate cancer	6.94e-05	0.000506	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Capecitabine—prostate cancer	6.92e-05	0.000504	CcSEcCtD
Pyridostigmine—Abdominal pain—Docetaxel—prostate cancer	6.91e-05	0.000504	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Prednisone—prostate cancer	6.87e-05	0.000501	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—prostate cancer	6.78e-05	0.000495	CcSEcCtD
Pyridostigmine—Paraesthesia—Prednisone—prostate cancer	6.77e-05	0.000493	CcSEcCtD
Pyridostigmine—Urticaria—Capecitabine—prostate cancer	6.72e-05	0.00049	CcSEcCtD
Pyridostigmine—Abdominal pain—Capecitabine—prostate cancer	6.69e-05	0.000488	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—prostate cancer	6.68e-05	0.000487	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—prostate cancer	6.64e-05	0.000484	CcSEcCtD
Pyridostigmine—Rash—Etoposide—prostate cancer	6.63e-05	0.000483	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—prostate cancer	6.62e-05	0.000483	CcSEcCtD
Pyridostigmine—Headache—Etoposide—prostate cancer	6.59e-05	0.00048	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—prostate cancer	6.58e-05	0.00048	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—prostate cancer	6.49e-05	0.000473	CcSEcCtD
Pyridostigmine—Hypersensitivity—Docetaxel—prostate cancer	6.44e-05	0.000469	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—prostate cancer	6.42e-05	0.000468	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—prostate cancer	6.35e-05	0.000463	CcSEcCtD
Pyridostigmine—Asthenia—Docetaxel—prostate cancer	6.27e-05	0.000457	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—prostate cancer	6.26e-05	0.000456	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—prostate cancer	6.25e-05	0.000455	CcSEcCtD
Pyridostigmine—Hypersensitivity—Capecitabine—prostate cancer	6.23e-05	0.000454	CcSEcCtD
Pyridostigmine—Feeling abnormal—Prednisone—prostate cancer	6.21e-05	0.000453	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Prednisone—prostate cancer	6.16e-05	0.000449	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—prostate cancer	6.15e-05	0.000448	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—prostate cancer	6.14e-05	0.000448	CcSEcCtD
Pyridostigmine—Asthenia—Capecitabine—prostate cancer	6.07e-05	0.000443	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—prostate cancer	6e-05	0.000438	CcSEcCtD
Pyridostigmine—Urticaria—Prednisone—prostate cancer	5.99e-05	0.000436	CcSEcCtD
Pyridostigmine—Diarrhoea—Docetaxel—prostate cancer	5.98e-05	0.000436	CcSEcCtD
Pyridostigmine—Abdominal pain—Prednisone—prostate cancer	5.96e-05	0.000434	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—prostate cancer	5.94e-05	0.000433	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—prostate cancer	5.87e-05	0.000428	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—prostate cancer	5.79e-05	0.000422	CcSEcCtD
Pyridostigmine—Diarrhoea—Capecitabine—prostate cancer	5.79e-05	0.000422	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—prostate cancer	5.7e-05	0.000415	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—prostate cancer	5.69e-05	0.000415	CcSEcCtD
Pyridostigmine—Vomiting—Docetaxel—prostate cancer	5.56e-05	0.000405	CcSEcCtD
Pyridostigmine—Hypersensitivity—Prednisone—prostate cancer	5.55e-05	0.000405	CcSEcCtD
Pyridostigmine—Rash—Docetaxel—prostate cancer	5.51e-05	0.000402	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—prostate cancer	5.51e-05	0.000402	CcSEcCtD
Pyridostigmine—Dermatitis—Docetaxel—prostate cancer	5.5e-05	0.000401	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—prostate cancer	5.5e-05	0.000401	CcSEcCtD
Pyridostigmine—Headache—Docetaxel—prostate cancer	5.47e-05	0.000399	CcSEcCtD
Pyridostigmine—Asthenia—Prednisone—prostate cancer	5.41e-05	0.000394	CcSEcCtD
Pyridostigmine—Vomiting—Capecitabine—prostate cancer	5.38e-05	0.000392	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.37e-05	0.000391	CcSEcCtD
Pyridostigmine—Rash—Capecitabine—prostate cancer	5.33e-05	0.000389	CcSEcCtD
Pyridostigmine—Dermatitis—Capecitabine—prostate cancer	5.33e-05	0.000389	CcSEcCtD
Pyridostigmine—Headache—Capecitabine—prostate cancer	5.3e-05	0.000386	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—prostate cancer	5.29e-05	0.000386	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—prostate cancer	5.27e-05	0.000384	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—prostate cancer	5.24e-05	0.000382	CcSEcCtD
Pyridostigmine—Nausea—Docetaxel—prostate cancer	5.19e-05	0.000378	CcSEcCtD
Pyridostigmine—Diarrhoea—Prednisone—prostate cancer	5.16e-05	0.000376	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—prostate cancer	5.1e-05	0.000372	CcSEcCtD
Pyridostigmine—Nausea—Capecitabine—prostate cancer	5.03e-05	0.000366	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.97e-05	0.000362	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—prostate cancer	4.9e-05	0.000357	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—prostate cancer	4.86e-05	0.000354	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—prostate cancer	4.85e-05	0.000353	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—prostate cancer	4.82e-05	0.000351	CcSEcCtD
Pyridostigmine—Vomiting—Prednisone—prostate cancer	4.79e-05	0.000349	CcSEcCtD
Pyridostigmine—Rash—Prednisone—prostate cancer	4.75e-05	0.000346	CcSEcCtD
Pyridostigmine—Dermatitis—Prednisone—prostate cancer	4.75e-05	0.000346	CcSEcCtD
Pyridostigmine—Headache—Prednisone—prostate cancer	4.72e-05	0.000344	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—prostate cancer	4.68e-05	0.000341	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—prostate cancer	4.66e-05	0.00034	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—prostate cancer	4.49e-05	0.000328	CcSEcCtD
Pyridostigmine—Nausea—Prednisone—prostate cancer	4.48e-05	0.000326	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—prostate cancer	4.46e-05	0.000325	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—prostate cancer	4.34e-05	0.000317	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—prostate cancer	4.33e-05	0.000316	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—prostate cancer	4.31e-05	0.000314	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—prostate cancer	4.23e-05	0.000308	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—prostate cancer	4.03e-05	0.000294	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—prostate cancer	4.02e-05	0.000293	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—prostate cancer	3.91e-05	0.000285	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—prostate cancer	3.75e-05	0.000273	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—prostate cancer	3.73e-05	0.000272	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—prostate cancer	3.72e-05	0.000271	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—prostate cancer	3.71e-05	0.000271	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—prostate cancer	3.69e-05	0.000269	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—prostate cancer	3.5e-05	0.000255	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—prostate cancer	3.47e-05	0.000253	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—prostate cancer	3.44e-05	0.000251	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—prostate cancer	3.44e-05	0.00025	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—prostate cancer	3.42e-05	0.000249	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—prostate cancer	3.24e-05	0.000236	CcSEcCtD
Pyridostigmine—BCHE—Metabolism—GSTA2—prostate cancer	2.33e-05	0.00036	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.3e-05	0.000356	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ABCG5—prostate cancer	2.3e-05	0.000356	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SULT1A1—prostate cancer	2.3e-05	0.000356	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.3e-05	0.000355	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC22A1—prostate cancer	2.28e-05	0.000352	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.27e-05	0.000351	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.25e-05	0.000348	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTA1—prostate cancer	2.25e-05	0.000347	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.24e-05	0.000346	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NAT2—prostate cancer	2.22e-05	0.000344	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTO1—prostate cancer	2.22e-05	0.000344	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HSD3B2—prostate cancer	2.22e-05	0.000344	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SULT2A1—prostate cancer	2.22e-05	0.000343	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.22e-05	0.000343	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.19e-05	0.000339	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MED12—prostate cancer	2.19e-05	0.000338	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GNG5—prostate cancer	2.17e-05	0.000335	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.14e-05	0.00033	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PLCB2—prostate cancer	2.13e-05	0.000329	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2C18—prostate cancer	2.13e-05	0.000329	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—LRP2—prostate cancer	2.13e-05	0.000329	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—COMT—prostate cancer	2.11e-05	0.000326	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.1e-05	0.000325	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—P4HB—prostate cancer	2.09e-05	0.000323	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NCOA3—prostate cancer	2.09e-05	0.000323	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.08e-05	0.000322	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.07e-05	0.00032	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.05e-05	0.000317	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC22A1—prostate cancer	2.03e-05	0.000314	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.01e-05	0.000311	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HPGDS—prostate cancer	1.99e-05	0.000308	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SULT2A1—prostate cancer	1.98e-05	0.000306	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2C19—prostate cancer	1.98e-05	0.000306	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—LEP—prostate cancer	1.97e-05	0.000304	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MED12—prostate cancer	1.95e-05	0.000301	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GNG5—prostate cancer	1.93e-05	0.000299	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTT1—prostate cancer	1.93e-05	0.000299	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.93e-05	0.000298	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2A6—prostate cancer	1.91e-05	0.000295	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.9e-05	0.000294	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.9e-05	0.000294	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.88e-05	0.00029	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NCOA3—prostate cancer	1.86e-05	0.000288	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—AKR1C3—prostate cancer	1.86e-05	0.000287	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PRKACB—prostate cancer	1.85e-05	0.000286	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.83e-05	0.000283	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.83e-05	0.000283	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP17A1—prostate cancer	1.83e-05	0.000283	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HAO1—prostate cancer	1.81e-05	0.000279	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.8e-05	0.000279	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.8e-05	0.000279	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HPGDS—prostate cancer	1.78e-05	0.000275	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2C19—prostate cancer	1.77e-05	0.000273	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—LEP—prostate cancer	1.75e-05	0.000271	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NCOA2—prostate cancer	1.74e-05	0.000269	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ACHE—prostate cancer	1.72e-05	0.000266	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTT1—prostate cancer	1.72e-05	0.000266	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2A6—prostate cancer	1.7e-05	0.000263	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.7e-05	0.000262	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—INS—prostate cancer	1.68e-05	0.000259	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC5A5—prostate cancer	1.66e-05	0.000257	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—AKR1C3—prostate cancer	1.66e-05	0.000256	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PRKACB—prostate cancer	1.65e-05	0.000255	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP17A1—prostate cancer	1.63e-05	0.000252	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2E1—prostate cancer	1.62e-05	0.000251	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF1—prostate cancer	1.62e-05	0.000251	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.61e-05	0.000249	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NQO1—prostate cancer	1.61e-05	0.000248	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—TH—prostate cancer	1.58e-05	0.000245	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.57e-05	0.000243	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MMP2—prostate cancer	1.57e-05	0.000243	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP3A4—prostate cancer	1.57e-05	0.000242	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.56e-05	0.000241	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NCOA2—prostate cancer	1.56e-05	0.00024	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1B1—prostate cancer	1.54e-05	0.000238	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—INS—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GGT1—prostate cancer	1.49e-05	0.00023	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC5A5—prostate cancer	1.48e-05	0.000229	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSAT1—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ADI1—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GRHL1—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TST—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CBR1—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CSAD—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NCOA1—prostate cancer	1.47e-05	0.000227	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2E1—prostate cancer	1.45e-05	0.000224	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF1—prostate cancer	1.45e-05	0.000224	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP19A1—prostate cancer	1.45e-05	0.000224	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NQO1—prostate cancer	1.43e-05	0.000221	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—TH—prostate cancer	1.41e-05	0.000218	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.4e-05	0.000217	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MMP2—prostate cancer	1.4e-05	0.000217	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP3A4—prostate cancer	1.4e-05	0.000216	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—RXRA—prostate cancer	1.4e-05	0.000216	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.39e-05	0.000215	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1B1—prostate cancer	1.37e-05	0.000212	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.37e-05	0.000211	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CKMT2—prostate cancer	1.37e-05	0.000211	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.37e-05	0.000211	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GRHPR—prostate cancer	1.37e-05	0.000211	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.36e-05	0.00021	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—COMT—prostate cancer	1.35e-05	0.000208	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTP1—prostate cancer	1.34e-05	0.000207	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GGT1—prostate cancer	1.33e-05	0.000206	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ITPR1—prostate cancer	1.32e-05	0.000204	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NCOA1—prostate cancer	1.31e-05	0.000202	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.31e-05	0.000202	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.3e-05	0.0002	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP19A1—prostate cancer	1.29e-05	0.0002	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—RFK—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AOX1—prostate cancer	1.29e-05	0.000199	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—RXRA—prostate cancer	1.25e-05	0.000193	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—TYMS—prostate cancer	1.25e-05	0.000192	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTM1—prostate cancer	1.23e-05	0.00019	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AMACR—prostate cancer	1.22e-05	0.000188	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.22e-05	0.000188	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.22e-05	0.000188	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NAT1—prostate cancer	1.22e-05	0.000188	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.22e-05	0.000188	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.21e-05	0.000187	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—LPL—prostate cancer	1.21e-05	0.000187	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	1.2e-05	0.000186	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—COMT—prostate cancer	1.2e-05	0.000186	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTP1—prostate cancer	1.2e-05	0.000185	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ITPR1—prostate cancer	1.18e-05	0.000182	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1A1—prostate cancer	1.17e-05	0.00018	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CXCL8—prostate cancer	1.16e-05	0.00018	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.16e-05	0.00018	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ERCC2—prostate cancer	1.16e-05	0.000179	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.16e-05	0.000179	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—TYMS—prostate cancer	1.11e-05	0.000172	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTM1—prostate cancer	1.1e-05	0.00017	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MTHFR—prostate cancer	1.09e-05	0.000168	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—LPL—prostate cancer	1.08e-05	0.000167	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARA—prostate cancer	1.07e-05	0.000165	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1A1—prostate cancer	1.04e-05	0.000161	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HPGD—prostate cancer	1.04e-05	0.00016	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.04e-05	0.00016	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ERCC2—prostate cancer	1.03e-05	0.00016	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CAV1—prostate cancer	1e-05	0.000155	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	9.75e-06	0.000151	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MTHFR—prostate cancer	9.71e-06	0.00015	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.59e-06	0.000148	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARA—prostate cancer	9.52e-06	0.000147	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP7B1—prostate cancer	9.49e-06	0.000147	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MTAP—prostate cancer	9.49e-06	0.000147	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SULT1E1—prostate cancer	9.25e-06	0.000143	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SRD5A1—prostate cancer	9.25e-06	0.000143	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CG—prostate cancer	9.14e-06	0.000141	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CAV1—prostate cancer	8.95e-06	0.000138	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ACSL4—prostate cancer	8.82e-06	0.000136	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD17B3—prostate cancer	8.82e-06	0.000136	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—INS—prostate cancer	8.65e-06	0.000134	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.55e-06	0.000132	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CREBBP—prostate cancer	8.47e-06	0.000131	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PHGDH—prostate cancer	8.46e-06	0.000131	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UMPS—prostate cancer	8.46e-06	0.000131	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ARG2—prostate cancer	8.46e-06	0.000131	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LDHB—prostate cancer	8.29e-06	0.000128	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CG—prostate cancer	8.15e-06	0.000126	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP3A5—prostate cancer	8.14e-06	0.000126	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CD—prostate cancer	8.04e-06	0.000124	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PDHA1—prostate cancer	7.86e-06	0.000121	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UCP3—prostate cancer	7.86e-06	0.000121	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA3—prostate cancer	7.86e-06	0.000121	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TCN2—prostate cancer	7.86e-06	0.000121	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—INS—prostate cancer	7.72e-06	0.000119	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NOS3—prostate cancer	7.59e-06	0.000117	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CREBBP—prostate cancer	7.56e-06	0.000117	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD3B1—prostate cancer	7.5e-06	0.000116	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC22A3—prostate cancer	7.5e-06	0.000116	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TBXAS1—prostate cancer	7.19e-06	0.000111	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA4—prostate cancer	7.19e-06	0.000111	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CD—prostate cancer	7.17e-06	0.000111	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA2—prostate cancer	7.01e-06	0.000108	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CB—prostate cancer	7e-06	0.000108	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS2—prostate cancer	6.94e-06	0.000107	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.92e-06	0.000107	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ABCG5—prostate cancer	6.92e-06	0.000107	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NOS3—prostate cancer	6.77e-06	0.000105	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA1—prostate cancer	6.76e-06	0.000104	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTO1—prostate cancer	6.68e-06	0.000103	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NAT2—prostate cancer	6.68e-06	0.000103	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HSD3B2—prostate cancer	6.68e-06	0.000103	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PLCB2—prostate cancer	6.41e-06	9.9e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LRP2—prostate cancer	6.41e-06	9.9e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2C18—prostate cancer	6.41e-06	9.9e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—P4HB—prostate cancer	6.28e-06	9.71e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CB—prostate cancer	6.25e-06	9.65e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS2—prostate cancer	6.19e-06	9.57e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC22A1—prostate cancer	6.11e-06	9.45e-05	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTEN—prostate cancer	6.05e-06	9.35e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.96e-06	9.21e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MED12—prostate cancer	5.86e-06	9.06e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GNG5—prostate cancer	5.81e-06	8.98e-05	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—EP300—prostate cancer	5.77e-06	8.92e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NCOA3—prostate cancer	5.6e-06	8.65e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTEN—prostate cancer	5.4e-06	8.34e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HPGDS—prostate cancer	5.34e-06	8.26e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.31e-06	8.2e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ACHE—prostate cancer	5.18e-06	8.01e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTT1—prostate cancer	5.18e-06	8.01e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—EP300—prostate cancer	5.15e-06	7.96e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.12e-06	7.92e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.98e-06	7.7e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PRKACB—prostate cancer	4.96e-06	7.66e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.91e-06	7.58e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NCOA2—prostate cancer	4.67e-06	7.22e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.46e-06	6.89e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.36e-06	6.73e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NQO1—prostate cancer	4.31e-06	6.66e-05	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CA—prostate cancer	4.27e-06	6.6e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TH—prostate cancer	4.24e-06	6.56e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.13e-06	6.38e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GGT1—prostate cancer	4e-06	6.18e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NCOA1—prostate cancer	3.94e-06	6.09e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.88e-06	6e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CA—prostate cancer	3.81e-06	5.89e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—RXRA—prostate cancer	3.75e-06	5.79e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—COMT—prostate cancer	3.61e-06	5.58e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTP1—prostate cancer	3.59e-06	5.55e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ITPR1—prostate cancer	3.53e-06	5.46e-05	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—AKT1—prostate cancer	3.49e-06	5.39e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TYMS—prostate cancer	3.34e-06	5.16e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTM1—prostate cancer	3.3e-06	5.1e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LPL—prostate cancer	3.24e-06	5.01e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.13e-06	4.84e-05	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—AKT1—prostate cancer	3.11e-06	4.81e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ERCC2—prostate cancer	3.1e-06	4.8e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MTHFR—prostate cancer	2.92e-06	4.51e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARA—prostate cancer	2.86e-06	4.42e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CAV1—prostate cancer	2.69e-06	4.16e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.45e-06	3.79e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—INS—prostate cancer	2.32e-06	3.59e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CREBBP—prostate cancer	2.27e-06	3.51e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.15e-06	3.33e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NOS3—prostate cancer	2.03e-06	3.14e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.88e-06	2.9e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.86e-06	2.88e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTEN—prostate cancer	1.62e-06	2.51e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—EP300—prostate cancer	1.55e-06	2.39e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.14e-06	1.77e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AKT1—prostate cancer	9.35e-07	1.45e-05	CbGpPWpGaD
